(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GENESILENCER

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

GENESILENCER

ST13

US500000076416007

Class

1

Filing

76416007

Registration

2785132

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

06/11/2024

Trademark type

Word

Nice classes

1

Filing date

06/06/2002

Registration date

11/18/2003

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/11/2024

Last transaction

06/11/2024

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Supplemental Register

First use anywhere

04/21/2002

First use in commerce

06/03/2002

Drawing code

1

Owner type

24

Owner location

ABINGDON, GB

Examiner

HICKEY,TONI

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

AMS BIOTECHNOLOGY (EUROPE) LTD
Gene Therapy Systems, Inc.

Representatives

Maria V. Stout KNOBBE, MARTENS, OLSON & BEAR LLP

Technical classification

Nice Classes

Class 1

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

REAGENTS FOR SCIENTIFIC OR MEDICAL RESEARCH USE

Publications

History of USPTO decisions and trademark events.

31 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

06/11/2024

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

06/11/2024

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

06/11/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/11/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

03/07/2024

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

07/26/2023

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

11/18/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

08/07/2017

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

08/07/2017

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

12/07/2013

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

12/07/2013

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

12/07/2013

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/07/2013

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

11/19/2013

E89R

TEAS SECTION 8 & 9 RECEIVED

11/19/2013

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

11/19/2009

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/19/2009

ES8R

TEAS SECTION 8 RECEIVED

11/18/2009

CFIT

CASE FILE IN TICRS

02/18/2009

CORV

REVIEW OF CORRESPONDENCE COMPLETE

09/09/2006

MAIL

PAPER RECEIVED

06/07/2004

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

11/18/2003

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

09/15/2003

GNEA

EXAMINERS AMENDMENT E-MAILED

09/10/2003

GNFR

FINAL REFUSAL E-MAILED

06/11/2003

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/17/2003

MAIL

PAPER RECEIVED

03/17/2003

CNRT

NON-FINAL ACTION MAILED

09/17/2002

DOCK

ASSIGNED TO EXAMINER

09/16/2002

DOCK

ASSIGNED TO EXAMINER

09/13/2002

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/01/2002

Continuous trademark protection

Get notified about every new filing that threatens GENESILENCER or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.